Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase

To study the effects of modestly increased expression of aldosterone synthase (AS), we generated mice (AShi/hi) by replacing the 3′ untranslated region of AS mRNA with that from a stable mRNA. AShi/hi mice on a normal-salt diet had 1.5 times the wild-type AS mRNA in adrenals, although their blood pressure and plasma aldosterone did not differ from wild-type mice. Changes in dietary salt did not affect the blood pressure of wild-type mice, but AShi/hi mice had ≈10-mm Hg higher blood pressure on a high-salt diet than on a low-salt diet and than wild-type mice on either diet. The AShi/hi mice on a high-salt diet also had higher plasma aldosterone, lower plasma potassium, and greater renal expression of the &agr; subunit of epithelial sodium channel compared with wild-type mice. The AShi/hi mice on a high-salt diet also had more water intake and urine volume and less urine osmolality than wild-type mice. On a low-salt diet, AShi/hi mice maintained normal blood pressure with less activation of the renin-angiotensin-aldosterone system than wild-type mice. The AShi/hi mice also had less water intake and urine volume and higher urine osmolality than wild-type mice. On a medium high-salt diet, AShi/hi mice were more susceptible than wild-type mice to infusion of angiotensin II, having a higher blood pressure, greater cardiac hypertrophy, and increased oxidative stress. Thus, a modest increase in AS expression makes blood pressure more sensitive to salt, suggesting that genetically increased AS expression in humans may contribute to hypertension and cardiovascular complications in societies with high-salt diets.

[1]  Hyung-Suk Kim,et al.  Disturbed Homeostasis in Sodium-Restricted Mice Heterozygous and Homozygous for Aldosterone Synthase Gene Disruption , 2006, Hypertension.

[2]  Dexter L. Lee,et al.  Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. , 2006, American journal of physiology. Heart and circulatory physiology.

[3]  Y. Toya,et al.  Expression of endothelial nitric oxide synthase is suppressed in the renal vasculature of angiotensinogen-gene knockout mice , 2006, Cell and Tissue Research.

[4]  J. Pratt,et al.  Central role for ENaC in development of hypertension. , 2005, Journal of the American Society of Nephrology : JASN.

[5]  N. Brown Aldosterone and end-organ damage. , 2005, Current opinion in nephrology and hypertension.

[6]  T. Mune,et al.  Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2 , 2005, Journal of hypertension.

[7]  E. Gomez-Sanchez,et al.  Effect of 3beta-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  S. Humphries,et al.  The -344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men. , 2004, Atherosclerosis.

[9]  Y. Tsai,et al.  Altering the expression in mice of genes by modifying their 3' regions. , 2004, Developmental cell.

[10]  F. Leenen,et al.  Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. , 2003, American journal of physiology. Heart and circulatory physiology.

[11]  B. Morris,et al.  Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension , 2003, Journal of hypertension.

[12]  J. C. Romero,et al.  Role of oxidative stress in angiotensin-induced hypertension. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[13]  J. Delyani,et al.  Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. , 2002, Endocrinology.

[14]  K. Weber,et al.  Aldosterone-induced inflammation in the rat heart : role of oxidative stress. , 2002, The American journal of pathology.

[15]  G. Regolisti,et al.  High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. , 2002, American journal of hypertension.

[16]  N. Markandu,et al.  Importance of the Renin System for Determining Blood Pressure Fall With Acute Salt Restriction in Hypertensive and Normotensive Whites , 2001, Hypertension.

[17]  A. Wielant,et al.  Influence of aldosterone on collagen synthesis and proliferation of rat cardiac fibroblasts , 2001, British journal of pharmacology.

[18]  W. Welch,et al.  Effects of dietary salt intake on plasma arginine. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  C. Gomez-Sanchez,et al.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. , 2000, The Journal of clinical endocrinology and metabolism.

[20]  F. Veglio,et al.  CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. , 2000, Hypertension.

[21]  N. Samani,et al.  Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction. , 2000, American journal of hypertension.

[22]  J. Wade,et al.  Aldosterone-mediated regulation of ENaC α, β, and γ subunit proteins in rat kidney , 1999 .

[23]  I. Miyamori,et al.  Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. , 1999, The Journal of clinical endocrinology and metabolism.

[24]  J. Connell,et al.  Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. , 1999, Hypertension.

[25]  P. D. de Leeuw,et al.  Sensitivity of blood pressure and renin activation during sodium restriction. , 1997, Hypertension.

[26]  W. Miller,et al.  Genetic variation in P450c11AS in Chilean patients with low renin hypertension. , 1996, The Journal of clinical endocrinology and metabolism.

[27]  N. Maeda,et al.  Single-copy transgenic mice with chosen-site integration. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Lifton Molecular Genetics of Human Blood Pressure Variation , 1996, Science.

[29]  J. P. Tolins,et al.  Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. , 1993, The Journal of clinical investigation.

[30]  J. Sullivan,et al.  Sodium Sensitivity in Human Subjects: Hemodynamic and Hormonal Correlates , 1988, Hypertension.

[31]  H. Wald,et al.  Water handling by the sabra hypertension prone (SBH) and resistant (SBN) rats , 1985, Pflügers Archiv.

[32]  M. Sabbatini,et al.  Mechanism of impaired urinary concentrating ability in normokalemic primary aldosteronism. , 1984, Clinical nephrology.

[33]  G. H. Kim,et al.  Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. , 1999, The Journal of clinical investigation.

[34]  X. Jeunemaître,et al.  Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension. , 1997, Pathologie-biologie.

[35]  J. Brown,et al.  Relation of Blood Pressure and Body Sodium Content During Sodium Depletion in Normal and Hypertensive Subjects , 1984, Journal of cardiovascular pharmacology.